surmount-1 trial tirzepatide obesity without diabetes weight loss (ZEPBOUND) Approved for Chronic Management in Adults with ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or How Did Diabetes Medications Become

Ozempic is FDA-approved for type 2 diabetes management, while Wegovy is FDA-approved for chronic weight management in adults with obesity or overweight

Covered by most private plans

However, they work differently

[2] [3] [4] Warn patients about the potential for somnolence, dizziness, confusion, difficulty concentrating, or visual effects, and advise patients against driving or operating machinery until they have gained sufficient experience on topiramate to gauge whether it adversely affects their mental performance, motor performance, and/or vision

When choosing between them, consider the potential side effects based on your health goals